Download in electronic PDF format for $25



Search the Complete Journal Archives

Compounding Pharmacies: Before and After an Inspection

Author(s):  Kulkarni Darshan, Ricketts Samantha

Issue:  Sep/Oct 2013 - Volume 17, Number 5
View All Articles in Issue

Abstract:  Recent events have directed the U.S. Food and Drug Administration’s attention to compounding pharmacies and have increased the frequency and vigorousness of pharmacy inspections. It is critical for compounding pharmacists to be prepared for such inspections and to understand their responsibilities after an inspection is over.

Related Keywords: Darshan Kulkarni, PharmD, MS, Esq, Samantha Ricketts, BA, regulatory agency, regulation, U.S. Food and Drug Administration, FDA, United States Pharmacopeia, USP, good manufacturing practices, GMP, compounded sterile preparations, drug safety, audit, pharmacy inspection, response team, privileged information

Related Categories: BUSINESS, ENVIRONMENTAL , LEGAL, STERILE PREPARATIONS, QUALITY CONTROL, UNITED STATES PHARMACOPEIA CONVENTIONS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Compounding Pharmacies: Before and After an Inspection Kulkarni Darshan, Ricketts Samantha Sep/Oct 2013 358-362 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug Mar/Apr 2017 95-102 Buy
Documentation: Records and Reports Akers Michael J Sep/Oct 2017 373-380 Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G Jul/Aug 2015 303-305 Buy
PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions Allen Loyd V Jr Sep/Oct 2013 356 Buy
Applying Quality of Design Concepts to Pharmacy Compounding Timko Robert J Nov/Dec 2015 453-463 Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr Nov/Dec 2015 487-488 Buy
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake Sep/Oct 2015 377-380 Buy